Designed specifically for the VIDAS family of instruments, the VIDAS SARS-CoV-2 IgM Assay is a critical tool in the detection of IgM antibodies against SARS-CoV-2, indicating recent or ongoing COVID-19 infection.
Authorized for emergency use by the FDA, this assay provides reliable results for critical COVID-19 testing scenarios.
Eligible for use in CLIA-certified laboratories, capable of performing moderate to high complexity tests, ensuring accurate and dependable results.
Leverages the advanced ELFA (Enzyme Linked Fluorescent Assay) technology for high sensitivity and specificity in COVID-19 IgM detection.
Each kit contains materials for 60 tests, making it suitable for high-volume testing environments.
Storage requirements include refrigeration, maintaining the integrity and effectiveness of the reagent.
